Taylor, L., Crockett, J., Tayo, B., & Morrison, G. (2019). A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment. J Clin Pharmacol.
Citação norma ChicagoTaylor, Lesley, Julie Crockett, Bola Tayo, and Gilmour Morrison. "A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment." J Clin Pharmacol 2019.
MLA CitationTaylor, Lesley, Julie Crockett, Bola Tayo, and Gilmour Morrison. "A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment." J Clin Pharmacol 2019.